Jane Carleton

700 total citations
9 papers, 528 citations indexed

About

Jane Carleton is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Jane Carleton has authored 9 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Oncology. Recurrent topics in Jane Carleton's work include Cancer therapeutics and mechanisms (2 papers), Neuroendocrine Tumor Research Advances (2 papers) and Renin-Angiotensin System Studies (2 papers). Jane Carleton is often cited by papers focused on Cancer therapeutics and mechanisms (2 papers), Neuroendocrine Tumor Research Advances (2 papers) and Renin-Angiotensin System Studies (2 papers). Jane Carleton collaborates with scholars based in United States, Switzerland and Canada. Jane Carleton's co-authors include Kari Chansky, Primo N. Lara, J. Philip Kuebler, Ronald B. Natale, John Crowley, Heinz Josef Lenz, Mary W. Redman, James R. Jett, Shaker R. Dakhil and Corey J. Langer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Jane Carleton

8 papers receiving 516 citations

Peers

Jane Carleton

ONCOL

EPIDE

MB

PRM

CCM

G. Dane United Kingdom

Giuseppe Valmadre Italy

Jonas A. Scheiber Germany

Christina Salvador Austria

Zhenhua Tu China

Alfredo Fucito Italy

Adela Cimic United States

D.S. Fairweather United Kingdom

Justin Yu United States

Jianjun Gu China

G. Dane United Kingdom

Jane Carleton

803 ×2.0

ONCOL

595 ×1.9

EPIDE

433 ×1.6

MB

244 ×2.4

PRM

11 ×0.2

CCM

Citations per year, relative to Jane Carleton Jane Carleton (= 1×) peers G. Dane

Countries citing papers authored by Jane Carleton

Since Specialization

Citations

This map shows the geographic impact of Jane Carleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Carleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Carleton more than expected).

Fields of papers citing papers by Jane Carleton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Carleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Carleton. The network helps show where Jane Carleton may publish in the future.

Co-authorship network of co-authors of Jane Carleton

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Carleton. A scholar is included among the top collaborators of Jane Carleton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Carleton. Jane Carleton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Carleton, Jane, et al.. (2025). Understanding the role of Shroom3 in the developing mouse myocardium. PLoS ONE. 20(9). e0331583–e0331583.

2.

Philip, Tony, et al.. (2019). Using a geographic and interdisciplinary strategy to improve patient care outcomes.. Journal of Clinical Oncology. 37(27_suppl). 78–78. 1 indexed citations

3.

Benedict, Catherine, Bridgette Thom, Eleonora Teplinsky, Jane Carleton, & Joanne Frankel Kelvin. (2016). Family-building After Breast Cancer: Considering the Effect on Adherence to Adjuvant Endocrine Therapy. Clinical Breast Cancer. 17(3). 165–170. 12 indexed citations

4.

Lara, Primo N., Ronald B. Natale, John Crowley, et al.. (2009). Phase III Trial of Irinotecan/Cisplatin Compared With Etoposide/Cisplatin in Extensive-Stage Small-Cell Lung Cancer: Clinical and Pharmacogenomic Results From SWOG S0124. Journal of Clinical Oncology. 27(15). 2530–2535. 393 indexed citations

5.

Natale, Ronald B., Primo N. Lara, Kari Chansky, et al.. (2008). S0124: A randomized phase III trial comparing irinotecan/cisplatin (IP) with etoposide/cisplatin (EP) in patients (pts) with previously untreated extensive stage small cell lung cancer (E-SCLC). Journal of Clinical Oncology. 26(15_suppl). 7512–7512. 27 indexed citations

6.

Pratt, Richard E., Jane Carleton, Timothy P. Roth, & Victor J. Dzau. (1988). Evidence for Two Cellular Pathways of Renin Secretion by the Mouse Submandibular Gland*. Endocrinology. 123(4). 1721–1727. 14 indexed citations

7.

Dzau, V J, Jane Carleton, & Thomas Brody. (1987). Sequential changes in renin secretion synthesis coupling in response to acute beta adrenergic stimulation. Clinical research. 35(3). 604. 7 indexed citations

8.

Wood, Jeanette M., Hans‐Peter Baum, Jane Carleton, & Victor J. Dzau. (1987). Inhibition of Renin-Like Activity in Marmoset Tissues by the Renin Inhibitor CGP 29 287. Journal of Hypertension. 5(2). S67–S69. 8 indexed citations

9.

Pratt, Richard E., Jane Carleton, John P. Richie, C H Heusser, & V J Dzau. (1987). Human renin biosynthesis and secretion in normal and ischemic kidneys.. Proceedings of the National Academy of Sciences. 84(22). 7837–7840. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact